Article

Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from Romania

2013-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 93ca1a37-0fe8-5352-8f77-b31378e989af
DOI: 10.1186/1471-2334-13-s1-p59
PMCID: PMC3882556

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from RomaniaDOI 10.1186/1471-2334-13-s1-p59Read

Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the telaprevir early access program in patients from RomaniaSemantic proximity Read

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C.Semantic proximity Read

EASL recommendations on treatment of hepatitis C 2014.Semantic proximity Read

EASL Recommendations on Treatment of Hepatitis C 2016.Semantic proximity Read

Hepatitis C therapy update.Semantic proximity Read

PSG consensus statement on management of hepatitis C virus infection--2003.Semantic proximity Read

SASLT practice guidelines: management of hepatitis C virus infection.Semantic proximity Read

Time for change: conventional interferon regimes should not be the standard of care for management of Pakistani genotype-3 in chronic hepatitis C.Semantic proximity Read

How to optimize HCV therapy in genotype 1 patients: management of side-effects.Semantic proximity Read

Pharmacological management of adverse events during treatment of chronic viral hepatitis in three Ivorian university hospitals .Semantic proximity Read

Focus on hepatitis. Final APRICOT, ACTG A5071 results.Semantic proximity Read

[Clinical use of telaprevir: stopping rules, predicting response, treatment length, and management of adverse effects].Semantic proximity Read